Intrinsic Value of S&P & Nasdaq Contact Us

Maravai LifeSciences Holdings, Inc. MRVI

NASDAQ Global Select

SharesGrow Score
43/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.50
+37.2%

Maravai LifeSciences Holdings, Inc. (MRVI) current share price is $3.28. The gold spot price is $4,808.10 per troy ounce. Using the formula: MRVI in gold = $3.28 × 31.1035 ÷ $4,808.10 = 0.0212 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of MRVI when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding MRVI shares over the measured period.

MRVI in US Dollars
Gold in US Dollars
MRVI in Gold (grams per share)

Real Wealth Growth Rate

MRVI
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{MRVI}_{\text{gold}}(t) = \frac{P_{\text{MRVI}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{MRVI}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{MRVI}_{\text{gold}}^{(T)}}{\text{MRVI}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{MRVI}_\text{gold}^{(0)}$ = initial gold-price, $\text{MRVI}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

ARGX
ARGX
argenx SE
$828.35
+2.36%
INSM
INSM
Insmed Incorporated
$153.40
+1.50%
ROIV
ROIV
Roivant Sciences Ltd.
$29.12
+0.59%
INCY
INCY
Incyte Corporation
$97.69
+2.24%
ASND
ASND
Ascendis Pharma A/S
$249.84
+0.52%
RXDX
RXDX
Prometheus Biosciences, Inc.
$199.92
+0.09%
CERE
CERE
Cerevel Therapeutics Holdings, Inc.
$44.96
+0.74%
CYTK
CYTK
Cytokinetics, Incorporated
$66.35
-0.55%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message